DE412557T1 - Wachstumsfaktor aus parenchymalen lebenszellen, dafuer kodierendes gen, verfahren zur herstellung dieses faktors und transformanten. - Google Patents
Wachstumsfaktor aus parenchymalen lebenszellen, dafuer kodierendes gen, verfahren zur herstellung dieses faktors und transformanten.Info
- Publication number
- DE412557T1 DE412557T1 DE199090115397T DE90115397T DE412557T1 DE 412557 T1 DE412557 T1 DE 412557T1 DE 199090115397 T DE199090115397 T DE 199090115397T DE 90115397 T DE90115397 T DE 90115397T DE 412557 T1 DE412557 T1 DE 412557T1
- Authority
- DE
- Germany
- Prior art keywords
- factor
- growth factor
- parenchymal
- transformers
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1209449A JP2577091B2 (ja) | 1989-08-11 | 1989-08-11 | 肝実質細胞増殖因子及びそれをコードする遺伝子 |
JP2088592A JP3036782B2 (ja) | 1990-04-03 | 1990-04-03 | ヒト肝実質細胞増殖因子の生産方法および該因子を産生する形質転換体 |
JP2200898A JP2963163B2 (ja) | 1990-07-27 | 1990-07-27 | ヒト肝実質細胞増殖因子 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE412557T1 true DE412557T1 (de) | 1991-07-04 |
Family
ID=27305852
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69030539T Expired - Lifetime DE69030539T2 (de) | 1989-08-11 | 1990-08-10 | Wachstumsfaktor aus parenchymalen Lebenszellen, dafür kodierendes Gen, Verfahren zur Herstellung dieses Faktors und Transformanten |
DE199090115397T Pending DE412557T1 (de) | 1989-08-11 | 1990-08-10 | Wachstumsfaktor aus parenchymalen lebenszellen, dafuer kodierendes gen, verfahren zur herstellung dieses faktors und transformanten. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69030539T Expired - Lifetime DE69030539T2 (de) | 1989-08-11 | 1990-08-10 | Wachstumsfaktor aus parenchymalen Lebenszellen, dafür kodierendes Gen, Verfahren zur Herstellung dieses Faktors und Transformanten |
Country Status (7)
Country | Link |
---|---|
US (1) | US5500354A (de) |
EP (1) | EP0412557B1 (de) |
KR (1) | KR960006122B1 (de) |
AT (1) | ATE152124T1 (de) |
CA (1) | CA2022752C (de) |
DE (2) | DE69030539T2 (de) |
HU (1) | HUT58798A (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9003621D0 (en) * | 1990-02-16 | 1990-04-11 | Imp Cancer Res Tech | Protein factor |
JP2784455B2 (ja) * | 1990-05-09 | 1998-08-06 | 敏一 中村 | 肝硬変治療剤 |
EP0461560B1 (de) * | 1990-06-11 | 1998-11-18 | Toshikazu Nakamura | Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung |
JP2750372B2 (ja) * | 1990-06-19 | 1998-05-13 | 敏一 中村 | 賢疾患治療剤 |
DK0539590T3 (da) * | 1990-07-13 | 1999-10-11 | Snow Brand Milk Products Co Ltd | Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog |
JP3200609B2 (ja) * | 1990-12-28 | 2001-08-20 | 敏一 中村 | 上皮細胞増殖促進剤 |
TW318142B (de) * | 1991-06-03 | 1997-10-21 | Mitsubishi Chemicals Co Ltd | |
EP0550296A3 (en) * | 1991-11-28 | 1993-12-29 | Terumo Corp | Vascular endothelial cells growth factor |
US5328837A (en) * | 1992-05-18 | 1994-07-12 | Genentech, Inc. | Hepatocyte growth factor protease domain variants |
EP0642580B1 (de) * | 1992-05-18 | 2002-08-21 | Genentech, Inc. | Hepatozytwachstumfaktor Variante |
US5316921A (en) * | 1992-05-18 | 1994-05-31 | Genentech, Inc. | Single-chain hepatocyte growth factor variants |
CA2102463A1 (en) * | 1992-11-05 | 1994-05-06 | Mitsubishi Chemical Corporation | Protein and gene encoding said protein |
GB9301453D0 (en) * | 1993-01-26 | 1993-03-17 | Clonit Spa | Nucleotide proves |
US5807711A (en) * | 1993-03-23 | 1998-09-15 | Taisho Pharmaceutical Co., Ltd. | Parenchymal hepatocyte growth factors |
CZ298364B6 (cs) * | 1998-02-05 | 2007-09-05 | Smithkline Beecham Biologicals S. A. | Deriváty antigenu asociovaných s nádory z MAGE rodiny a sekvence nukleových kyselin kodující tyto deriváty, jejich použití pro prípravu fúzních proteinu a prostredku pro vakcinaci |
US7129064B2 (en) | 2000-06-22 | 2006-10-31 | Nippon Zenyaku Kogyo Ltd. | Canine hepatocyte growth factor |
KR20020097319A (ko) * | 2001-06-20 | 2002-12-31 | 윤재승 | 사람 간세포 성장인자 코딩 벡터, 형질전환 균주 및이로부터 발현된 재조합 단백질 |
KR100562824B1 (ko) | 2002-03-20 | 2006-03-23 | 주식회사 바이로메드 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
US20090202606A1 (en) * | 2008-01-25 | 2009-08-13 | Viromed Co., Ltd. | Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
AU2009234598C1 (en) * | 2008-04-09 | 2012-08-23 | Viromed Co., Ltd. | Lyophilized DNA formulations for enhanced expression of plasmid DNA |
US9272018B2 (en) | 2011-04-18 | 2016-03-01 | Kyoto University | Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof |
JP6240337B2 (ja) | 2013-10-22 | 2017-11-29 | バイロメッド カンパニー リミテッド | 肝細胞増殖因子の2つ以上のアイソフォームを利用した筋萎縮性側索硬化症の予防又は治療用組成物 |
KR101808192B1 (ko) * | 2016-08-26 | 2018-01-18 | 아미코젠주식회사 | 7-아미노세팔로스포란산의 고농도 생산 재조합 아크레모니움 크리소제눔 균주의 제조방법 및 이 방법으로 제조된 균주 |
EP3823677A4 (de) | 2018-07-19 | 2022-06-01 | Helixmith Co., Ltd. | Lyophilisierte pharmazeutische zusammensetzungen für nackte dna-gentherapie |
-
1990
- 1990-08-07 CA CA002022752A patent/CA2022752C/en not_active Expired - Lifetime
- 1990-08-10 DE DE69030539T patent/DE69030539T2/de not_active Expired - Lifetime
- 1990-08-10 DE DE199090115397T patent/DE412557T1/de active Pending
- 1990-08-10 EP EP90115397A patent/EP0412557B1/de not_active Expired - Lifetime
- 1990-08-10 AT AT90115397T patent/ATE152124T1/de not_active IP Right Cessation
- 1990-08-10 HU HU904957A patent/HUT58798A/hu unknown
- 1990-08-11 KR KR1019900012415A patent/KR960006122B1/ko not_active IP Right Cessation
-
1993
- 1993-07-09 US US08/089,417 patent/US5500354A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0412557B1 (de) | 1997-04-23 |
HUT58798A (en) | 1992-03-30 |
ATE152124T1 (de) | 1997-05-15 |
EP0412557A1 (de) | 1991-02-13 |
KR960006122B1 (ko) | 1996-05-09 |
US5500354A (en) | 1996-03-19 |
KR910004803A (ko) | 1991-03-29 |
CA2022752A1 (en) | 1991-02-12 |
DE69030539T2 (de) | 1997-09-11 |
DE69030539D1 (de) | 1997-05-28 |
HU904957D0 (en) | 1991-01-28 |
CA2022752C (en) | 1998-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE412557T1 (de) | Wachstumsfaktor aus parenchymalen lebenszellen, dafuer kodierendes gen, verfahren zur herstellung dieses faktors und transformanten. | |
ATE140960T1 (de) | Verfahren zur herstellung von zellen, die stabil integrierte fremde dns mit hoher kopiezahl enthalten, durch dieses verfahren hergestellte zellen und verwendung dieser zellen zur herstellung von durch diese fremde dns kodierten polypeptiden | |
DE3856446D1 (de) | Alpha-amidierende Enzymzusammensetzungen und Verfahren zu deren Herstellung und Verwendung | |
ATE91716T1 (de) | Verfahren zur herstellung vielkettige polypeptide oder proteine. | |
DE3789866T2 (de) | DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung. | |
ATE402260T1 (de) | Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung | |
ATE46536T1 (de) | Verfahren zur herstellung von reifen proteinen in wirtzellen von wirbeltieren. | |
DE69920747D1 (de) | Methode zur herstellung von rekombinanten zellen | |
ATE135740T1 (de) | Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung | |
ATE124454T1 (de) | Gentechnische herstellung von faktor xiiia. | |
DE69430975T2 (de) | Verfahren zur Herstellung von Proteinen | |
BR8406680A (pt) | Processo para preparacao de um plasmidio,processo para expressao eficiente de proteinas heterologas,para preparacao de um transformante e processo para producao de prorrenina | |
DE69130704D1 (de) | Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns-sequencen, und ihre herstellung und vewendung. | |
DE3856229D1 (de) | Verfahren zur Herstellung rekombinanter Polypeptide mit Schweine-Wachstumshormonaktivität | |
DE69939876D1 (de) | Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren | |
ATE50453T1 (de) | Spezifisches polypeptid produzierende hybridzellinien, erhaeltlich aus primaerzellen, die spontan faehig sind zur expres sion dieses polypeptids oder eines aehnlichen polypeptids, verfahren zum erhalten dieser hybridzellen und deren verwendung zur herstellung dieses polypeptids. | |
DE69031996D1 (de) | Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung | |
DE69132845T2 (de) | Verfahren zur Herstellung von Proteinen durch Verwendung von CKS-Fusionsproteinen | |
ATA435083A (de) | Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen | |
DE3669529D1 (de) | Hybridzellen, die ein hepatitis-b-virus-antigen produzieren, aus hepatocyten und errichteten affenzellen, verfahren zur herstellung dieser hybridzellen und verwendung derselben zur herstellung der obenerwaehnten antigens. |